Ramadi leads the Laboratory for Neuroengineering and Translational Medicine at NYU Abu Dhabi. In 2023, he led a team of researchers from LANTRN and MIT to develop an ingestible capsule that can be used to treat obesity, anorexia, and other medical conditions that benefit from adjusting someone's food intake. Currently, they are collaborating with clinicians at Cleveland Clinic Abu Dhabi and Brigham and Women’s Hospital in the U.S. to conduct clinical and human trials. LANTRN has also developed a non-toxic approach to upcycle plastic bags and masks into quantum dots, a specific type of nanoparticle with economic value.